Variation in Physician’s Recommendation of Blood Pressure Self-Monitoring in the United States: Results from Nhanes 2009 – 2014

Abstract

S65pre-(baseline) and 12-month post-(follow-up) index hospitalization were included. Patients who had previous evidence of ACS or prescription of antiplatelet agents during baseline period or had major adverse cardiovascular events within the initial 30 days after discharge were excluded. Patients who had a ≥ 80% proportion of days covered (PDC) were considered adherent, while patients who had no gaps of ≥ 30 days in antiplatelet therapy were considered persistent. Logistic and Cox models were used to explore the associated factors for adherence and persistence, respectively. ReSultS: 5,486 patients (63.2±10.8 years; 60.2% male) were identified. Only 10.9% (N= 600) of them were adherent to antiplatelet agents during follow-up, and the mean PDC was 0.39±0.29 for the total cohort. 90.1% (N= 4,942) patients discontinued antiplatelet agents during follow-up and the average time to discontinuation was 103.89±110.27 days. Male, patients who received percutaneous coronary intervention (PCI) or those who had longer stay during index hospitalization had better adherence (Odds ratio [95%